Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.11B P/E - EPS this Y 24.00% Ern Qtrly Grth -
Income -31.6M Forward P/E 242.86 EPS next Y 63.20% 50D Avg Chg -11.00%
Sales 169.6M PEG - EPS past 5Y - 200D Avg Chg -19.00%
Dividend N/A Price/Book 4.20 EPS next 5Y - 52W High Chg -36.00%
Recommedations 3.00 Quick Ratio 3.37 Shares Outstanding 124.34M 52W Low Chg 41.00%
Insider Own 66.62% ROA -5.83% Shares Float 40.67M Beta 0.50
Inst Own 34.60% ROE -6.92% Shares Shorted/Prior 2.32M/1.67M Price 17.00
Gross Margin 67.49% Profit Margin -18.63% Avg. Volume 109,659 Target Price 26.00
Oper. Margin -9.23% Earnings Date May 9 Volume 60,119 Change -5.50%
About Olink Holding AB (publ)

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

Olink Holding AB (publ) News
04/19/24 Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
04/02/24 Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
03/28/24 Olink Holding AB (publ) (NASDAQ:OLK) Just Reported And Analysts Have Been Cutting Their Estimates
03/27/24 These Analysts Think Olink Holding AB (publ)'s (NASDAQ:OLK) Sales Are Under Threat
03/25/24 Olink reports fourth quarter and full year 2023 financial results
03/25/24 Olink publishes 2023 annual report
03/15/24 Notice to attend the Annual General Meeting of Olink Holding AB (publ)
03/08/24 Olink announces change of date for Annual General Meeting
03/01/24 Companies Like Olink Holding (NASDAQ:OLK) Can Afford To Invest In Growth
02/06/24 Thermo Fisher Scientific Inc. (NYSE:TMO) Q4 2023 Earnings Call Transcript
12/30/23 Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment
11/15/23 Olink reports third quarter 2023 financial results
11/14/23 Breakeven On The Horizon For Olink Holding AB (publ) (NASDAQ:OLK)
11/08/23 Why Earnings Season Could Be Great for Olink (OLK)
11/05/23 Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
11/03/23 Should You Still Buy the Nasdaq's Best-Performing October Stocks?
11/02/23 Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for
10/25/23 Q3 2023 Thermo Fisher Scientific Inc Earnings Call
10/25/23 Thermo Fisher Scientific (TMO) Q3 2023 Earnings Call Transcript
10/18/23 Arm initiated, SQM downgraded: Wall Street's top analyst calls
OLK Chatroom

User Image Stock_Titan Posted - 4 days ago

$OLK Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024 https://www.stocktitan.net/news/OLK/report-from-the-annual-general-meeting-of-olink-holding-ab-publ-on-uh8ukq8fnj1v.html

User Image Stocksrunner Posted - 6 days ago

Warren Buffett's advice to be greedy when others are fearful applies to $ARGX $BLTE and $OLK Technical analysis shows these stocks are in oversold territory, which could present a buying opportunity for risk-tolerant investors.

User Image Stock_Titan Posted - 3 weeks ago

$OLK Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease https://www.stocktitan.net/news/OLK/olink-r-insight-unveils-open-access-map-of-the-human-proteome-aiding-gq2wqu02kkib.html

User Image DonCorleone77 Posted - 03/25/24

$OLK Olink will not host conference call Due to the pending acquisition of Olink by Thermo Fisher Scientific Inc., Olink will not be hosting a conference call.

User Image DonCorleone77 Posted - 03/25/24

$OLK Olink reports Q4 EPS (6c), consensus 15c Reports Q4 revenue $68.6M, consensus $89.86M.

User Image Stock_Titan Posted - 03/25/24

$OLK Olink reports fourth quarter and full year 2023 financial results https://www.stocktitan.net/news/OLK/olink-reports-fourth-quarter-and-full-year-2023-financial-3yu0kuyaay14.html

User Image Stock_Titan Posted - 1 month ago

$OLK Notice to attend the Annual General Meeting of Olink Holding AB (publ) https://www.stocktitan.net/news/OLK/notice-to-attend-the-annual-general-meeting-of-olink-holding-ab-rkzhchyxolpj.html

User Image Stock_Titan Posted - 1 month ago

$OLK Olink announces change of date for Annual General Meeting https://www.stocktitan.net/news/OLK/olink-announces-change-of-date-for-annual-general-18bccosmu3dt.html

User Image G101SPM Posted - 1 month ago

#OPTIONACTION $OLK March 23 Calls (volume: 8008, open int: 0, implied vol: ~181%, prev day implied vol: 23%). $LBRT June 25 Calls (volume: 1000, open int: 0, implied vol: ~64.64%, prev day implied vol: 38.64%). Co is expected to report earnings in mid April. $SIRI April 3.5 Puts (volume: 3001, open int: 0, implied vol: ~89.26%, prev day implied vol: 60.26%). Co is expected to report earnings in late April. $WAL March 57 Puts (volume: 1699, open int: 27, implied vol: ~91.3%, prev day implied vol: 65.3%). Co is expected to report earnings in mid April.

User Image TickerDD_com Posted - 1 month ago

From 3/1/2024, looking back across 22 Month-Ends for OLK, Percentage Change of Average Monthly Price had More Negatives (55%) while Percentage Change of Average Monthly Volume had More Positives (95%) $OLK #OLK #OLKStock #TickerDD #OLKPrice https://www.youtube.com/watch?v=hqQHtSpBxx0

User Image CTFNLighthouse Posted - 1 month ago

$OLK $TMO Thermo Fisher Scientific extended the expiration date of its $26-per-share tender offer for Olink. The offer is now scheduled to expire at 5pm ET on April 30. As of February 29, approximately 95.2% of Olink’s outstanding shares have been validly tendered into the offer.

User Image Mergerbrief Posted - 2 months ago

$OLK $TMO - UK CMA(Comment Period Expires) Mergerbrief.com

User Image DailyStocksPicks Posted - 2 months ago

My Oversold Stock Pick #4 Today: Olink Holding AB (publ) ($OLK) analyzes proteins for medical insights.The oversold status of Olink Holding AB (publ) (OLK) stock can largely be attributed to the news that Thermo Fisher Scientific Inc. plans to acquire Olink. This significant development reflects the growing importance of proteomics in advancing life science research and precision medicine, with Thermo Fisher intending to enhance its offerings by integrating Olink's pioneering proteomics technologies. The acquisition, backed by major shareholders and expected to close by mid-2024, is projected to initially dilute Thermo Fisher's adjusted earnings per share, though it is anticipated to contribute positively in the longer term. This move has likely influenced market perceptions and led to the current trading condition of OLK stock​​​​. For more details https://youtu.be/ezSZP5XHe2I

User Image CTFNLighthouse Posted - 2 months ago

$OLK $TMO Olink’s share price dropped by nearly 8% after its proposed takeover by Thermo Fisher went into a Phase 2 review at the Bundeskartellamt. “The parties currently expect the Phase 2 review by the German Bundeskartellamt to be completed by mid 2024, which is consistent with the expected timeline of the other ongoing regulatory reviews, including the review by the [UK Competition and Markets Authority]," the parties said.

User Image DanielMontalvo1082 Posted - 2 months ago

As $OLK innovates in ophthalmology, COEP's enticing price targets from analysts suggest a bright future ahead.

User Image CTFNLighthouse Posted - 2 months ago

$OLK $TMO The UK Competition and Markets Authority has launched a review of Thermo Fisher Scientific's proposed acquisition of Olink. The invitation comment period will run from today, February 2, until February 23.

User Image tickeron Posted - 3 months ago

A.I.dvisor is predicting $OLK is about to fall. View odds of downtrend. https://srnk.us/go/4973765

User Image StockInvest_us Posted - 3 months ago

Signal alert: $OLK - Undervalued https://stockinvest.us/l/Vq3lm5fUhf

User Image risenhoover Posted - 3 months ago

$OLK / Olink Holding AB files form 6-K https://fintel.io/doc/sec-olink-holding-ab-publ-1835539-6k-2024-january-18-19740-777?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image tickeron Posted - 3 months ago

Is this good for your portfolio? $OLK RSI Indicator left the oversold zone. View odds of downtrend. https://srnk.us/go/4971158

User Image risenhoover Posted - 3 months ago

$OLK / Olink Holding AB files form SC 14D9/A https://fintel.io/doc/sec-olink-holding-ab-publ-1835539-sc-14d9a-2024-january-04-19726-5777?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image CTFNLighthouse Posted - 3 months ago

$OLK $TMO Thermo Fisher Scientific has extended the expiration date of its $26-per-share tender offer for Olink to 5pm ET on February 29. As of January 3, approximately 94.1% of the target’s outstanding shares have been tendered into the offer.

User Image CTFNLighthouse Posted - 3 months ago

$OLK $TMO Thermo Fischer’s $26-per-share tender offer for Olink is scheduled to expire at 5pm ET today.

User Image risenhoover Posted - 4 months ago

$OLK / Olink Holding AB files form SC 14D9/A https://fintel.io/doc/sec-olink-holding-ab-publ-1835539-sc-14d9a-2023-december-22-19713-378?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Mergerbrief Posted - 4 months ago

$OLK $TMO - Germany FCO Possibly expires mergerbrief.com

User Image StockInvest_us Posted - 4 months ago

Signal alert: $OLK - Undervalued https://stockinvest.us/l/34Ub3Wyc5R

User Image Stock_Titan Posted - 4 months ago

$SLGC $LAB $OLK Madryn Asset Management Issues Presentation Detailing Why SomaLogic Shareholders Should Vote “AGAINST” the Value-Destructive and Deeply Flawed Proposed Merger with Standard BioTools https://www.stocktitan.net/news/SLGC/madryn-asset-management-issues-presentation-detailing-why-soma-logic-6w10vuhmsmy7.html

User Image risenhoover Posted - 4 months ago

$OLK / Olink Holding AB (publ) - ADR files form SC 14D9/A https://fintel.io/doc/sec-olink-holding-ab-publ-1835539-sc-14d9a-2023-december-15-19706-7707?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 4 months ago

$OLK / Olink Holding AB (publ) - ADR files form SC 14D9/A https://fintel.io/doc/sec-olink-holding-ab-publ-1835539-sc-14d9a-2023-december-15-19706-3727?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Mergerbrief Posted - 4 months ago

$OLK $TMO - Tender Offer Expires mergerbrief.com

Analyst Ratings
Morgan Stanley Equal-Weight Mar 26, 24
Canaccord Genuity Hold Mar 26, 24
Morgan Stanley Equal-Weight Oct 24, 23
Scotiabank Sector Perform Oct 18, 23
Morgan Stanley Equal-Weight Aug 10, 23
Morgan Stanley Equal-Weight May 15, 23
Goldman Sachs Neutral Feb 23, 23
Morgan Stanley Equal-Weight Feb 22, 23
Goldman Sachs Neutral Feb 22, 23